These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36581096)

  • 21. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
    Hroudová J; Singh N; Fišar Z
    Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.
    Hikosaka K; Yaku K; Okabe K; Nakagawa T
    Nutr Neurosci; 2021 May; 24(5):371-383. PubMed ID: 31280708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
    Shacka JJ; Roth KA; Zhang J
    Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease.
    Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC
    Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic Resonance Elastography in the Study of Neurodegenerative Diseases.
    Feng Y; Murphy MC; Hojo E; Li F; Roberts N
    J Magn Reson Imaging; 2024 Jan; 59(1):82-96. PubMed ID: 37084171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
    Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
    Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.
    Scolari Grotto F; Glaser V
    Biometals; 2024 Feb; 37(1):3-22. PubMed ID: 37594582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases.
    Srivastava S; Haigis MC
    Curr Pharm Des; 2011; 17(31):3418-33. PubMed ID: 21902666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifaced role of protein deacetylase sirtuins in neurodegenerative disease.
    Gupta R; Ambasta RK; Kumar P
    Neurosci Biobehav Rev; 2022 Jan; 132():976-997. PubMed ID: 34742724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.
    Egensperger R; Kösel S; Schnopp NM; Mehraein P; Graeber MB
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):315-21. PubMed ID: 9292870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.
    Almikhlafi MA; Karami MM; Jana A; Alqurashi TM; Majrashi M; Alghamdi BS; Ashraf GM
    Curr Neuropharmacol; 2023; 21(5):1165-1183. PubMed ID: 36043795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ghrelin and Neurodegenerative Disorders-a Review.
    Shi L; Du X; Jiang H; Xie J
    Mol Neurobiol; 2017 Mar; 54(2):1144-1155. PubMed ID: 26809582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases.
    Klonarakis M; De Vos M; Woo EK; Ralph LT; Thacker JS; Gil-Mohapel J
    Neurosci Biobehav Rev; 2022 Apr; 135():104541. PubMed ID: 35063495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-hydroxynonenal and neurodegenerative diseases.
    Zarkovic K
    Mol Aspects Med; 2003; 24(4-5):293-303. PubMed ID: 12893007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglial cells in neurodegenerative disorders.
    Wojtera M; Sikorska B; Sobow T; Liberski PP
    Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders.
    Zilberter Y; Tabuena DR; Zilberter M
    Prog Neurobiol; 2023 Dec; 231():102539. PubMed ID: 37838279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitophagy Regulates Neurodegenerative Diseases.
    Cen X; Zhang M; Zhou M; Ye L; Xia H
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic metabolic analysis of potential target, therapeutic drug, diagnostic method and animal model applicability in three neurodegenerative diseases.
    Li WX; Li GH; Tong X; Yang PP; Huang JF; Xu L; Dai SX
    Aging (Albany NY); 2020 May; 12(10):9882-9914. PubMed ID: 32461378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics in animal models of Alzheimer's and Parkinson's diseases.
    Sowell RA; Owen JB; Butterfield DA
    Ageing Res Rev; 2009 Jan; 8(1):1-17. PubMed ID: 18703168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
    Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.